Earnings Feed
Start Free
Home/Filings/4/0001178913-18-000195
4//SEC Filing

Eini Meir 4

Accession 0001178913-18-000195

CIK 0001606645other
View on SEC.govCompany Profile

Filed

Jan 17, 7:00 PM ET

Accepted

Jan 18, 5:10 PM ET

Size

24.6 KB

Accession

0001178913-18-000195

Insider Transaction Report

Form 4
Period: 2018-01-02
Foamix Pharmaceuticals Ltd.FOMX
Eini Meir
Other
Transactions
  • Sale

    Ordinary Shares

    2018-01-10$6.05/sh−5,000$30,227→ 2,722,781 total(indirect: See footnote)
  • Exercise/Conversion

    Restricted Share Units

    2018-01-01−5,032→ 15,098 total
    → Ordinary Shares (5,032 underlying)
  • Sale

    Ordinary Shares

    2018-01-02$6.18/sh−5,000$30,903→ 2,752,781 total(indirect: See footnote)
  • Exercise/Conversion

    Ordinary Shares

    2018-01-15+1,125→ 17,396 total
  • Sale

    Ordinary Shares

    2018-01-03$6.26/sh−5,000$31,311→ 2,747,781 total(indirect: See footnote)
  • Sale

    Ordinary Shares

    2018-01-04$6.68/sh−5,000$33,411→ 2,742,781 total(indirect: See footnote)
  • Sale

    Ordinary Shares

    2018-01-05$6.58/sh−5,000$32,882→ 2,737,781 total(indirect: See footnote)
  • Sale

    Ordinary Shares

    2018-01-08$6.17/sh−5,000$30,850→ 2,732,781 total(indirect: See footnote)
  • Exercise/Conversion

    Restricted Share Units

    2018-01-15−1,125→ 4,500 total
    → Ordinary Shares (1,125 underlying)
  • Sale

    Ordinary Shares

    2018-01-09$6.10/sh−5,000$30,520→ 2,727,781 total(indirect: See footnote)
  • Sale

    Ordinary Shares

    2018-01-11$6.33/sh−5,000$31,659→ 2,717,781 total(indirect: See footnote)
  • Exercise/Conversion

    Ordinary Shares

    2018-01-01+5,032→ 16,271 total
Footnotes (5)
  • [F1]These transactions were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on September 6, 2017
  • [F2]Shares held by Meir Eini Holdings Ltd., an Israeli company owned and controlled by the reporting person
  • [F3]The Restricted Share Units convert into Ordinary Shares on a one-for-one basis
  • [F4]The Restricted Share Units vest over a period of four years (25% on January 1, 2018 and 6.25% every three months thereafter) ending January 1, 2018
  • [F5]The Restricted Share Units vest in equal installments every three months over the vesting period ending January 15, 2019

Documents

1 file

Issuer

Foamix Pharmaceuticals Ltd.

CIK 0001606645

→
Entity typeother

Related Parties

1
  • filerCIK 0001631964

Filing Metadata

Form type
4
Filed
Jan 17, 7:00 PM ET
Accepted
Jan 18, 5:10 PM ET
Size
24.6 KB
View on SEC.gov